Search

This study provides a comprehensive review of recent advancements in photocatalytic and electrocatalytic carbon dioxide reduction using titanium dioxide catalysts. The basic concepts of light absorption, electron transport, and reduction processes are introduced in this paper, which also delves into the specifics of photocatalytic and electrocatalytic reduction of carbon dioxide. The paper highlights the key applications and benefits of titanium dioxide, including its strong stability, outstanding light absorption capacity, and good electron transport performance, in the photocatalytic and electrocatalytic reduction of carbon dioxide. Furthermore, it examines the impact of various surface modification techniques on catalytic performance, as well as the effects of various titanium dioxide catalyst forms on catalytic activity and selectivity in carbon dioxide reduction. The in‐depth analysis exhibit promising catalytic properties and hold significant potential for future advancements. However, some obstacles still need to be overcome, such as increasing catalytic activity and selectivity while minimizing energy dissipation. In order to improve catalytic performance and efficiency, future research should prioritize the optimization of structural design and surface modification techniques for catalysts. Additionally, the paper provides a scientific foundation for accomplishing sustainable carbon conversion, it also calls for additional experimental and theoretical research into the mechanism of action for titanium dioxide catalyst. [ABSTRACT FROM AUTHOR]

Background The aim of this study was to investigate the gene expression profile of chronic obstructive pulmonary disease (COPD) patients and non-COPD patients. Methods Microarray raw data (GSE29133) was downloaded from Gene Expression Omnibus, including three COPD samples and three normal controls. Gene expression profiling was performed using Affymetrix human genome u133 plus 2.0 GeneChip. Differentially expressed genes were identified by Student's t test and genes with p < 0.05 were considered significantly changed. Up- and downregulated genes were submitted to the molecular signatures database (MSigDB) to search for a possible association with other previously published gene expression signatures. Furthermore, we constructed a COPD protein-protein interaction (PPI) network and used the connectivity map (cMap) to query for potential drugs for COPD. Results A total of 680 upregulated genes and 530 downregulated genes in COPD were identified. The MSigDB investigation found that upregulated genes were highly similar to gene signatures that respond to interferon and downregulated genes were similar to erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 knocked out. A PPI network consisting of 814 gene/proteins and 2,613 interactions was identified by Search Tool for the Retrieval of Interacting Genes. The cMap predicted helveticoside, disulfiram, and lanatoside C as the top three possible drugs that could perhaps treat COPD. Conclusion Comprehensive analysis of the gene expression profile for COPD versus control reveals helveticoside, disulfiram, and lanatoside C as potential molecular targets in COPD. This evidence provides a new breakthrough in the medical treatment of patients with COPD., Author(s): Hong Bao[sup.1] , Jiaman Wang[sup.1] , Ding Zhou[sup.1] , Zhaoyong Han[sup.1] , Ling Su[sup.1] , Yuan Zhang[sup.1] , Xiong Ye[sup.1] , Chunyan Xu[sup.1] , Yuping Wang[sup.1] , Qinghua Li[sup.1] [...]